Moderna, Inc. (MRNA)
Nasdaq · Common stock · Biological Products, (no Diagnostic Substances)
As of Oct 21, 2:18 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.
Follow MRNA in real time
Real-time quotes, Pro Charting, the scanner and the alert feed on MRNA and every other US listing.
Start 5 days freeTry Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
MRNA at a glance
Key statistics
$96.65B
Market capitalization
- Previous close
- $242.08
- Open
- $242.00
- Day range
- $240.38 – $250.13
- Volume
- 9.74M
- Average volume (30 sessions)
- 16.74M
- Shares outstanding
- 399.24M
- Earnings per share
- $(7.89)
- Price / book
- 14.3
- Price / sales
- 43.4
- Beta (1 year, vs SPY)
- 2.04
Where the price sits in its year
52-week range
100% of the range
- Below the 52-week high
- -0.0%
- Above the 52-week low
- +1022.5%
Completed sessions through Oct 20, 2026
Technical snapshot
Above its 50-day and 200-day averages
- 20-day average
- $206.85+17.0%
- 50-day average
- $161.93+49.5%
- 200-day average
- $79.44+204.7%
Between the conventional 30 and 70 bands.
+11.9%
1 week
+40.0%
1 month
+316.9%
3 months
+720.9%
Year to date
+830.7%
1 year
Price change over each window, from completed sessions. Past performance does not indicate future results.
Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.The member platform, in real time
What members do with MRNA
MRNA on Pro Charting
Every intraday interval in real time, the drawing kit and the full set of technical studies on MRNA.
See the plans →
Every planScreen names like MRNA
The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.
See the plans →
Analysis Tools OnlySet a price line on MRNA
Put MRNA on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.
See the plans →
Stock Alerts + ToolsOpen alerts on MRNA
See whether there is an open premium alert on MRNA, with its entry, stop and exit, each one reviewed by an analyst before it is sent.
See the plans →
From the public news wire
MRNA headlines
- Moderna, Inc. to Join the Nasdaq-100 Index® Beginning October 9, 2026
GlobeNewswire Inc. · Oct 1, 2026
- mRNA Therapeutics Market Outlook Report 2026-2035 Featuring Profiles of Arcturus Therapeutics, BioNTech, CureVac, Moderna, Providence Therapeutics, RNAimmune, Recode Therapeutics, and More
GlobeNewswire Inc. · Aug 26, 2026
- Global Influenza Vaccine Market Report, 2026 Edition - Profiles GlaxoSmithKline, Pfizer, Sanofi, Moderna, and 9 Other Players
GlobeNewswire Inc. · Aug 7, 2026
SEC Form 4, most recent first
Insider filings
Hoge Stephen
+76.5K
President · Option exercise
$933.48K · Oct 15, 2026
Hoge Stephen
−76.5K
President · Option exercise
· Oct 15, 2026
Hoge Stephen
+76.5K
President · Option exercise
$933.49K · Oct 14, 2026
Hoge Stephen
−38.8K
President · Open-market sale
$8.28M · Oct 14, 2026
Hoge Stephen
−450
President · Open-market sale
$96.37K · Oct 14, 2026
Hoge Stephen
−39.1K
President · Open-market sale
$8.64M · Oct 15, 2026
Hoge Stephen
−76.5K
President · Option exercise
· Oct 14, 2026
Mock James M
−1.5K
Chief Financial Officer · Option exercise
· Oct 5, 2026
About Moderna, Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
- Exchange
- Nasdaq
- Security
- Common stock
- Industry
- Biological Products, (no Diagnostic Substances)
- Headquarters
- Cambridge, MA
- Employees
- 4,700
- Listed since
- Dec 7, 2018
- Website
- modernatx.com
Pick the desk that fits how you trade
Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.
Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.